GlycoMimetics to Report Second Quarter 2023 Financial Results on August 2, 2023
19 7월 2023 - 8:00PM
Business Wire
GlycoMimetics, Inc. (Nasdaq: GLYC), today announced that it will
host a conference call and webcast to report second quarter 2023
financial results on Wednesday, August 2, 2023, at 8:30 a.m.
ET.
To access the call by phone, please go to this registration link
and you will be provided with dial in details. Participants are
encouraged to connect 15 minutes in advance of the scheduled start
time.
A live webcast of the call will be available on the “Investors”
tab on the GlycoMimetics website. A webcast replay will be
available for 30 days following the call.
About GlycoMimetics, Inc.
GlycoMimetics is a late clinical-stage biotechnology company
discovering and developing glycobiology-based therapies for
cancers, including Acute Myeloid Leukemia, and for inflammatory
diseases with high unmet needs. The company’s science is based on
an understanding of the role that carbohydrates play in cell
recognition. Its specialized chemistry platform is deployed to
discover small molecule drugs--known as glycomimetics—that alter
carbohydrate-mediated recognition in diverse disease states. As a
leader in this science, GlycoMimetics leverages its unique approach
to advance a pipeline of wholly-owned drug candidates with the goal
of developing transformative therapies for diseases with high unmet
need. GlycoMimetics is headquartered in Rockville, MD in the
BioHealth Capital Region. Learn more at www.glycomimetics.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230719484385/en/
Investor Contact: Argot Partners Leo Vartorella
212-600-1902 Glycomimetics@argotpartners.com
GlycoMimetics (NASDAQ:GLYC)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
GlycoMimetics (NASDAQ:GLYC)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024
